Our Business

Takeda's journey will expand and advance the translation of science into highly-innovative medicines while maintaining its agility as a global, values-based, R&D-driven, biopharmaceutical leader.

Our Products

We are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Our R&D efforts are focused on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.



Our manufacturing, engineering, quality assurance and supply chain capabilities are continuously improved. We are seeking out innovation through digital science, partnerships and conducting our business in a sustainable way, fostering a speak up culture for people and product safety.

Learn more

Alliances & Partnerships

At Takeda, we seek partners who believe our global reach, scientific expertise and clinical excellence can help them bring their vision to patients. We seek innovation and partner to nurture it, wherever it resides.


Access to Medicines

Through our Access to Medicines strategy, we are expanding on our existing commitments to enhance global health so that eligible patients in evolving healthcare systems can have access to our innovative and potentially life-saving medicines, even if their ability to pay for the full cost of treatment is limited



A joint program between Takeda and Center for iPS Cell Research and Application (CiRA) that will change the future of medicine using iPS cells

Learn more